RecruitingNot ApplicableNCT07396766

Dissemination of BREASTChoice AIM1-B

Dissemination of a Breast Reconstruction Decision Tool Through Social Media and Online Communities- AIM1-B

Sponsor

UNC Lineberger Comprehensive Cancer Center

Enrollment

20 participants

Start Date

Oct 1, 2025

Study Type

INTERVENTIONAL

Conditions

Breast Cancer Breast Neoplasms

Summary

This registration covers only Aim 1b, which focuses on testing usability. The study will include 20 participants who are breast cancer patients. Participants will be observed using the tool on their mobile devices, and their experience will be evaluated using a "think-aloud" method to capture their thoughts and reactions. Interviews will include open-ended questions about the content and format of the decision aid, with follow-up prompts to gather feedback on design elements (length, order, graphics), comprehension, ease of use, acceptance, and engagement with the tool. Knowledge will be measured using the Decision Quality Instrument before and after using the tool. Results will be analyzed to develop recommendations for the final version of the tool.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a decision-support tool called BREASTChoice, designed to help breast cancer survivors who have had a mastectomy or lumpectomy think through their options for breast reconstruction or no reconstruction. The goal is to learn how well this tool works in real-world clinical settings. **You may be eligible if...** - You are 18 or older - You can read and speak English - You have had a mastectomy or lumpectomy for breast cancer within the past 8 years - You have not yet made a final decision about breast reconstruction **You may NOT be eligible if...** - You have already completed or decided against breast reconstruction - Your breast surgery was for a reason other than cancer (e.g., a preventive procedure without a cancer diagnosis) - You are unable to participate in the study procedures Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALBaseline Questionnaire

Participants will be screened and share demographic information during screening. If eligible and screened in, the interviewer will send the self-administered pre-survey Decision Quality Index (DQI).

BEHAVIORALSemi structured Interview

Participants will participate in a semi-structured interview and review of the adapted BREASTChoice tool.

BEHAVIORALPost Survey

Participants will take the post-survey to assess breast reconstruction decision quality.

Locations(1)

The University of North Carolina

Chapel Hill, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07396766

Related Trials

Genomic Services Research Program

NCT025959571 location

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

NCT0717375183 locations

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

NCT07060807174 locations

PREgnancy and FERtility Registry

NCT0289516523 locations

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

NCT070671381 location